WaferGen Bio systems : September 28th, 2015 - WaferGen Biosystems to Participate in the Ladenburg Thalmann 2015 Healthcare Conference

28September2015

FREMONT, Calif., Sept. 28, 2015 - WaferGen Bio-systems, Inc. (WGBS) announced today that Rollie Carlson, President and CEO, will present a corporate update at the Ladenburg Thalmann 2015 Healthcare Conference in New York, NY on September 29, 2015.

Ladenburg Thalmann 2015 Healthcare Conference
Date: Tuesday, September 29, 2015
Time: 3:00 pm Eastern Time
Location: Sofitel Hotel, Track 2, Odeon Room
The presentation will be webcast live and archived for 30 days on WaferGen's Investor Relations website at
http://ir.wafergen.com

About WaferGen

WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.

For additional information, please see http://www.wafergen.com

Contact:
INVESTOR CONTACTS:
LifeSci Advisors, LLC
Brian Ritchie
BRitchie@LifeSciAdvisors.com
WaferGen Bio-systems, Inc.
Rollie Carlson
Rollie.Carlson@wafergen.com